EUVIMEDEUVIMED entdecken
Open Access

Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei

Mojtaba Rostamighadi iD, Arezou Kamelshahroudi, Vanessa Pitsitikas, Kenneth A Jacobson iD, Reza Salavati

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Mojtaba Rostamighadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, McGill University, Ste. Anne de Bellevue, Quebec H9X 3 V9, Canada. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, RNA Editing, Uridine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIAID NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma brucei bruceiRNA EditingUridineTrypanocidal AgentsHumansDrug Evaluation, PreclinicalProtozoan ProteinsMolecular Docking SimulationDrug RepositioningCatechin

Stichwörter der Autor:innen

FRET-based assaysNIH clinical collectionRNA editingkinetoplastidsmode of action studypilot scale screening

Substanzen

UridineTrypanocidal AgentsProtozoan Proteinsepigallocatechin gallateCatechin

Autor:innen und Institutionen

  • Institute of Parasitology, McGill University, Ste. Anne de Bellevue, Quebec H9X 3 V9, Canada.
  • Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, 9000, Rockville Pike, Bethesda, Maryland 20892, United States.
  • Department of Biochemistry, McGill University, Montreal H3G 1Y6, Quebec, Canada.

ORCID-Profile: Mojtaba Rostamighadi, Kenneth A Jacobson

Förderung

  • Intramural NIH HHS
  • NIAID NIH HHS
  • National Institute of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program

Zitieren

APA

Rostamighadi, M., Kamelshahroudi, A., Pitsitikas, V., Jacobson, K. A., & Salavati, R. (2024). Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00394

Vancouver

Rostamighadi M, Kamelshahroudi A, Pitsitikas V, Jacobson KA, Salavati R. Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00394

BibTeX
@article{Rostamighadi2024,
  author = {Rostamighadi, Mojtaba and Kamelshahroudi, Arezou and Pitsitikas, Vanessa and Jacobson, Kenneth A and Salavati, Reza},
  title = {Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00394}
}
Kostenlos starten →